A detailed history of Shell Asset Management CO transactions in Pfizer Inc stock. As of the latest transaction made, Shell Asset Management CO holds 60,201 shares of PFE stock, worth $1.75 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
60,201
Previous 63,300 4.9%
Holding current value
$1.75 Million
Previous $1.76 Million 4.15%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 31, 2024

SELL
$25.89 - $29.73 $80,233 - $92,133
-3,099 Reduced 4.9%
60,201 $1.68 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $992,674 - $1.14 Million
-38,342 Reduced 37.72%
63,300 $1.76 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $638,486 - $829,323
-24,435 Reduced 19.38%
101,642 $2.93 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $1.06 Million - $1.24 Million
-32,949 Reduced 20.72%
126,077 $4.18 Million
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $738,726 - $854,689
-20,452 Reduced 11.4%
159,026 $5.83 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $84,137 - $109,534
2,136 Added 1.2%
179,478 $7.32 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $1.39 Million - $1.81 Million
-33,264 Reduced 15.79%
177,342 $9.09 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $2.25 Million - $2.75 Million
-51,456 Reduced 19.64%
210,606 $9.22 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $1.48 Million - $1.75 Million
31,714 Added 13.77%
262,062 $13.7 Million
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $3.45 Million - $4.28 Million
-75,438 Reduced 24.67%
230,348 $11.9 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $110,365 - $163,598
2,671 Added 0.88%
305,786 $18.1 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $3.62 Million - $4.66 Million
-92,337 Reduced 23.35%
303,115 $13 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $8.05 Million - $9.12 Million
-224,194 Reduced 36.18%
395,452 $15.5 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $730,416 - $823,763
-21,810 Reduced 3.4%
619,646 $22.5 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $200,987 - $255,572
-6,005 Reduced 0.93%
641,456 $23.6 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $125,984 - $147,808
-3,968 Reduced 0.61%
647,461 $23.8 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $4.16 Million - $5.04 Million
-137,993 Reduced 17.48%
651,429 $21.3 Million
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $1.37 Million - $1.95 Million
-50,621 Reduced 6.03%
789,422 $25.8 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $1.04 Million - $1.19 Million
-31,725 Reduced 3.64%
840,043 $32.9 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $1.75 Million - $2.27 Million
-53,861 Reduced 5.82%
871,768 $31.3 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $1.86 Million - $2.09 Million
-50,375 Reduced 5.16%
925,629 $40.1 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $1.54 Million - $1.69 Million
-41,012 Reduced 4.03%
976,004 $41.5 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $3.14 Million - $3.58 Million
-81,544 Reduced 7.42%
1,017,016 $44.4 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $3.7 Million - $4.49 Million
-107,277 Reduced 8.9%
1,098,560 $48.4 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $5.01 Million - $5.34 Million
-151,802 Reduced 11.18%
1,205,837 $43.7 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $3.86 Million - $4.48 Million
121,121 Added 9.8%
1,357,639 $48.2 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $4.4 Million - $4.67 Million
132,379 Added 11.99%
1,236,518 $44.8 Million
Q3 2017

Oct 20, 2017

SELL
$31.0 - $34.15 $21.7 Million - $24 Million
-701,508 Reduced 38.85%
1,104,139 $39.4 Million
Q3 2017

Oct 18, 2017

BUY
$31.0 - $34.15 $56 Million - $61.7 Million
1,805,647
1,805,647 $53.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.